A detailed history of Quadrant Capital Group LLC transactions in Natera, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 740 shares of NTRA stock, worth $111,821. This represents 0.01% of its overall portfolio holdings.

Number of Shares
740
Previous 738 0.27%
Holding current value
$111,821
Previous $79,000 18.99%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$97.75 - $129.67 $195 - $259
2 Added 0.27%
740 $94,000
Q1 2024

May 15, 2024

SELL
$59.21 - $92.9 $2,901 - $4,552
-49 Reduced 6.23%
738 $67,000
Q4 2023

Feb 08, 2024

BUY
$37.55 - $62.64 $4,843 - $8,080
129 Added 19.6%
787 $49,000
Q3 2023

Nov 14, 2023

SELL
$43.4 - $62.52 $10,285 - $14,817
-237 Reduced 26.48%
658 $29,000
Q2 2023

Aug 09, 2023

BUY
$47.08 - $55.16 $2,448 - $2,868
52 Added 6.17%
895 $43,000
Q1 2023

May 11, 2023

SELL
$36.57 - $58.29 $1,791 - $2,856
-49 Reduced 5.49%
843 $46,000
Q4 2022

Feb 10, 2023

SELL
$34.17 - $47.91 $4,476 - $6,276
-131 Reduced 12.81%
892 $35,000
Q3 2022

Nov 10, 2022

BUY
$36.93 - $56.68 $1,366 - $2,097
37 Added 3.75%
1,023 $45,000
Q2 2022

Aug 09, 2022

BUY
$28.13 - $44.54 $27,145 - $42,981
965 Added 4595.24%
986 $35,000
Q1 2022

May 06, 2022

SELL
$30.32 - $91.33 $272 - $821
-9 Reduced 30.0%
21 $0
Q4 2021

Feb 01, 2022

BUY
$86.26 - $119.0 $172 - $238
2 Added 7.14%
30 $3,000
Q3 2021

Nov 12, 2021

BUY
$100.17 - $126.36 $2,504 - $3,159
25 Added 833.33%
28 $3,000
Q2 2021

Aug 09, 2021

SELL
$86.05 - $119.72 $86 - $119
-1 Reduced 25.0%
3 $0
Q1 2021

May 12, 2021

BUY
$91.47 - $124.36 $365 - $497
4 New
4 $0

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $14.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.